Andrew Miller, Ph.D.

Andrew Miller, Ph.D.

DirectoratKyverna Therapeutics· In the 2025 proxy

Andrew Miller, Ph.D. sits on 3 public boards.

Boards1

  • Kyverna TherapeuticsDirector · -1 yr on the boardIndependentAudit, Science and Technology—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Kyverna TherapeuticsPublic company · 1 yr
    • Director2025 – Present · 1 yrStock in role +49%
  2. Progentos TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  3. Entrega, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?